Ultrahuman Ring Pro

Overview

The Ultrahuman Ring Pro is Ultrahuman’s redesigned vehicle to legally re-enter the US smart-ring market after the company’s Ring AIR was import-banned by the ITC in 2024 following Oura’s patent litigation. The Pro launched in May 2026 with substantive hardware upgrades — a dual-core processor with on-chip ML, an upgraded heart rate sensor, longer battery (up to 15 days; 45 with the charging case) — and clean-sheet engineering specifically designed to navigate around Oura’s patent claims.

In the 2026 smart-ring landscape, Ultrahuman Ring Pro represents the most credible subscription-free flagship alternative to Oura Ring 4. Where Oura locks data behind a $5.99/month subscription and pursues aggressive patent enforcement against competitors, Ultrahuman’s pitch is ownership: pay once, keep your data. The Ring Pro is the buy-it-once answer for biohackers who don’t want subscription-tax over a multi-year horizon.

What We Measured

Note: This review is based on Ultrahuman’s published specifications, US launch documentation, and aggregated user reports from the global Ring AIR predecessor. Hands-on instrument testing with Polar H10 + Kubios HRV (Bland–Altman analysis on 7-day continuous wear) is pending. Verdict will be updated upon completion.

Hardware redesign vs Ring AIR

The Pro is not a re-skinned Ring AIR — it’s a substantively different device built to operate within Oura’s patent perimeter. Specific changes include sensor placement modifications, the new dual-core processor, and the on-chip ML pipeline. Whether these changes hold up against future Oura ITC challenges is the structural risk Ultrahuman buyers should price in.

Battery life

Up to 15 days continuous wear — longest in the consumer smart-ring category. With the optional charging case, total runtime extends to 45 days between wall charges. This is roughly 2.5× Oura Ring 4’s ~6-day battery and competitive with the longest-running competitors (RingConn Gen 2 at ~10 days). For travel-heavy users, the 45-day case is a genuine differentiator.

Sensor suite and metabolic-health integration

Sleep stages, HRV, SpO2, skin temperature, movement, recovery tracking. The standout feature for the Ultrahuman ecosystem is the M1 CGM integration — for users running continuous glucose monitoring, the Ring Pro becomes a data overlay on metabolic-health protocols. Most consumer-grade rings don’t have CGM-native pairing; this is one of two key Ultrahuman differentiators (the other being the PowerPlugs marketplace for third-party algorithms).

App and PowerPlugs marketplace

The Ultrahuman app is busier than Oura’s; PowerPlugs adds third-party modules (caffeine tracking, jet-lag protocols, sun exposure, etc.). Some users like the depth, others find it overwhelming. App-store ratings: 4.5 iOS, 4.1 Android.

3-Year Cost of Ownership

Component	Cost
Ultrahuman Ring Pro (current pricing range)	$349–$479
Subscription	$0 (none)
Optional charging case	included in higher tier
3-year total — flagship pricing	$349–$479

Compare: Oura Ring 4 ($349 hardware + $216 subscription = $565), RingConn Gen 2 ($299, no subscription = $299), Samsung Galaxy Ring ($399, no subscription = $399).

Ultrahuman Ring Pro sits at premium pricing for a subscription-free device, but undercuts Oura by about $86–$216 over 3 years depending on configuration. The TCO win is real if you’ll keep the ring 3+ years.

Regulatory Status

General Wellness Device. No FDA clearance or registration; markets under FDA’s general wellness policy. This is consistent with the entire consumer smart-ring category — Oura, RingConn, Samsung, Whoop all share this status. No smart ring is FDA-cleared as a medical device for any specific indication.

The Ring Pro’s regulatory posture is identical to its competitors. The legal exposure that matters is patent litigation, not FDA clearance.

The Patent-War Context

Ultrahuman’s first US-market ring, the Ring AIR, was import-banned in 2024 after Oura filed an ITC complaint and won an exclusion order. The Ring Pro is the company’s second attempt — engineered specifically to operate outside the contested patent claims. Oura has not (as of mid-2026) filed a new ITC challenge against the Ring Pro, which buyers may interpret as either:

1. Ultrahuman’s redesign successfully navigated the patent perimeter, or
2. Oura is waiting for sufficient market share to justify renewed litigation costs.

Either is plausible. Buyers should understand this is the structural risk Ultrahuman customers carry; it’s not present with Samsung Galaxy Ring (Samsung’s patent portfolio gives it defensive immunity) or Oura itself.

Verdict: Conditional

The Ultrahuman Ring Pro is the most credible subscription-free flagship alternative to Oura Ring 4 currently available in the US. The 15-day battery, on-chip ML, M1 CGM integration, and pay-once data ownership are real differentiators. For metabolic-health-focused biohackers and CGM users specifically, the Pro is the ring most aligned with that protocol.

The conditional verdict reflects two real risks: (1) the company’s still-young US presence means long-term support and warranty paths are less proven than Oura/Samsung’s; (2) the patent-war risk could re-surface if Oura challenges the Pro’s design in future litigation. The product itself is excellent; the brand and category context add uncertainty.

If you want subscription-free without patent risk, Samsung Galaxy Ring is the safer bet (and $50–$130 cheaper). If you want the deepest CGM integration and longest battery, Ultrahuman Ring Pro is the right answer. If you can absorb the subscription cost in exchange for the deepest published validation footprint, Oura Ring 4 remains the category benchmark.

Changelog

• 2026-05-05: Initial review published based on Ultrahuman’s launch specifications and global Ring AIR user-report data. Hands-on Polar H10 + Kubios HRV validation pending.